Showing results (11-20 of 2,878) with videos related to
Sort By:
Pageof 288
Expert Opinion on Investigational Drugs|October 11, 2011
Nebivolol for the treatment of heart failureNicoletta Riva, Gregory Y H LipExpert Review of Cardiovascular Therapy|June 10, 2009
Hypertension to heart failure: a pathophysiological spectrum relating blood pressure, drug treatments and strokeVeeran Subramaniam, Gregory Y H LipExpert Review of Cardiovascular Therapy|March 7, 2012
Highlights of the American Heart Association Scientific Sessions 2011: a focus on ATLAS-TIMI 51, TRACER and PALLASAlena Shantsila, Gregory Y H LipJournal of Translational Medicine|September 2, 2008
'Aspirin resistance' or treatment non-compliance: which is to blame for cardiovascular complications?Eduard Shantsila, Gregory Y H LipEuropean Heart Journal. Quality of Care & Clinical Outcomes|February 9, 2022
Targeted vs. full population screening costs for incident atrial fibrillation and AF-related stroke for a healthy population aged 65 years in the United KingdomPaul Burdett, Gregory Y H LipExpert Review of Cardiovascular Therapy|May 8, 2009
Antiarrhythmic drugs for atrial fibrillation: focus on dronedaroneSuresh Krishnamoorthy, Gregory Y H LipExpert Opinion on Investigational Drugs|November 20, 2002
Ongoing trials involving angiotensin-converting enzyme inhibitorsSunil Nadar, Gregory Y H LipBMC Cardiovascular Disorders|June 24, 2005
Peripheral arterial disease: a high risk - but neglected - disease populationJoseph Tomson, Gregory Y H LipPathophysiology of Haemostasis and Thrombosis|February 5, 2005
Virchow's triad revisited: blood constituentsIrene Chung, Gregory Y H LipExpert Opinion on Pharmacotherapy|February 3, 2025
Controversies and challenges of anticoagulation therapy in obesityThomas Salmon, Gregory Y H LipPageof 288